BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Lin X, Liu E, Jian Z, Ou Y. MicroRNA-33b regulates hepatocellular carcinoma cell proliferation, apoptosis, and mobility via targeting Fli-1-mediated Notch1 pathway. J Cell Physiol 2020;235:7635-44. [PMID: 32239672 DOI: 10.1002/jcp.29673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Yu J, Cheng S, Peng Z, Ben-David Y, Luo H. Transcription factor Fli-1 as a new target for antitumor drug development. Int J Biol Macromol 2022;209:1155-68. [PMID: 35447268 DOI: 10.1016/j.ijbiomac.2022.04.076] [Reference Citation Analysis]
2 Mei Y, Li K, Zhang Z, Li M, Yang H, Wang H, Huang X, Li X, Shi S, Yang H. miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer. Front Oncol 2021;11:740452. [PMID: 34804930 DOI: 10.3389/fonc.2021.740452] [Reference Citation Analysis]
3 Han M, Liao Z, Liu F, Chen X, Zhang B. Modulation of the TGF-β signaling pathway by long noncoding RNA in hepatocellular carcinoma. Biomark Res 2020;8:70. [PMID: 33292618 DOI: 10.1186/s40364-020-00252-x] [Reference Citation Analysis]
4 Huang HQ, Chen G, Xiong DD, Lai ZF, Liu LM, Fang YY, Shen JH, Gan XY, Liao LF, Dang YW. Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma. Bioengineered 2021;12:1627-41. [PMID: 33949293 DOI: 10.1080/21655979.2021.1921549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]